Archive: Recommended Stocks & Mutual
Funds in the News
08/20/2004
--- Two
Most Recent Blue-Chip Picks Already Beating the Market, Making
Profit In Down Market
Eaton Vance Corp. (EV) and Claire's Stores, Inc. (CLE), our
two most recent recommendations for our High-Dividend
Blue Chip Stock Portfolio are already showing an average
gain of 14.1%. The S&P 500 has fallen over the same time
span. Both companies reported quarterly earnings this week
and both beat analyst estimates, causing the stocks to rise
10.46% & 11.99%, respectively, this week alone.
Making a profit in a down market usually
isn't easy, but this
portfolio's returns have almost doubled that of the S&P
500 (26.1% per year versus 14.7% for the S&P 500).
08/13/2004
--- Takeover
Bid Pushes Stock Up 36.7% In One Day
First National Bankshares of Florida (ticker: FLB) was an
attractive takeover candidate when we recommended the stock.
On August 2, Fifth Third Bancorp agreed to acquire FLB, sending
FLB's stock up 36.7%. To discover other takeover candidates
in our Primary Stock Portfolio, subscribe
today.
08/07/2004
--- Cimarex
Net Income Up 74%, Stock Up 72.6%
On Wednesday, Cimarex Energy Co. reported that net income
increased 74% over year-ago net income of $21 million. The
company's stock has risen 72.6% after we recommended the company,
including a 45.1% increase in the last twelve months. Cimarex
Energy Co. is an independent oil and gas exploration and production
company with operations focused in Mid-Continent and Gulf
Coast areas of the U.S.
06/25/2004
--- Gen-Probe
Up 8.1% This Week and Up 275.2% Overall
How Gen-Probe (GPRO) has done for us: +275.2% in the 17 months
since our buy signal. Positive things seem to be brewing for
this firm. Today's trading volume for Gen-Probe was 4 times
above normal, and after-hours trading exceeded a typical full
day's worth of trading. Including the after hours trading,
the price rose 4.7%. Despite the steady price rise this week
(+8.1%), there was no major news story concerning Gen-Probe.
Definitely keep an eye on this stock come Monday.
06/25/2004
--- Nearly
Half-Way Through the Year, We're Quadrupling the S&P 500's
Return
Nearly half-way through the year, our Primary Stock Portfolio
is quadrupling the S&P 500's return (12.6% versus 2.4%
for the S&P 500). Over the last twelve months, our Primary
Stock Portfolio is up 49.9% while the S&P 500 is up only
15.9%. In 2003, our Primary Stock Portfolio was up 55.8%.
05/29/2004
--- S&P
Revises Zimmer Outlook from Stable to Positive
On Friday, Standard & Poor's Ratings Services revised
its outlook for Zimmer Holdings from "stable" to
"positive." Zimmer Holdings Inc. is an orthopedic
implant manufacturer that we recommended buying in late 2001.
The stock has since risen 168.6% and has helped the Primary
Stock Portfolio achieve its 35.2% annual return.
05/29/2004
--- Marine
Products Corp. Rises 22.3% this Week & is Up 542.9% Overall
Marine Products Corporation, a boat manufacturer that we recommended
buying in the heart of the recession, saw its stock rise 22.3%
this week, despite the lack of any major news about the company.
Since our "buy" recommendation in 2001, the stock
has risen 542.9%.
05/21/2004
--- Zimmer
Holdings Inc. Referred to as "Head of the Medical Supplier
Class" by IBD
Zimmer Holdings Inc., a company whose stock has risen 163.2%
since we released our buy signal for the company, is referred
to as the head of the medical supplier class by Investor's
Business Daily (IBD). Some of the reasons include a 90% increase
in sales, 37% first-quarter earnings growth, and the smooth
acquisition of Centerpulse AG. The IBD article about Zimmer
can be found here.
04/16/2004
--- Escalon
Update: 9.2% Gain This Week Pushes Overall Gain to 62.1% in
Less Than a Month
We recommended buying Escalon Medical Corp. (ESMC) less than
a month ago and the stock has since gained 62.1% versus the
S&P 500's gain of only 1.9%. On the same day that we recommended
Escalon, we also recommended Greg Manning Auctions Inc. (GMAI).
GMAI has risen 57.5%. That's equivalent to an annualized rate
of 31,819.4%.
04/03/2004
--- Annualized
Gains: 319.6% versus 41.2%
In only ten trading days, our new Short Term Portfolio is
up 6.8% versus 2.6% for the S&P 500. Annualized, those
numbers equate to 319.6% and 41.2% respectively. The portfolio
is being lead by stocks like Greg Manning Auctions Inc. and
Escalon Medical Corp. The stocks of these two companies are
up 42.9% and 34.8% in ten trading days.
03/29/2004
--- 33% Gain
in Six Trading Days
Updating our note from Saturday, Greg Manning Auctions,
Inc. is now up 33.1% in the six trading days after
we recommended the stock. Today the firm's stock moved up
an additional 15.8%. Escalon Medical has
done almost nearly as well. Their stock rose 10.2% today and
is now up 31.6% after we recommended the stock on March 19.
03/27/2004
--- 14.9% Gain in Five Trading
Days
Two of the stocks in our Short Term Portfolio have already
made solid gains in the five trading days since we introduced
the portfolio. The first of the two stocks, Greg Manning
Auctions, Inc., revised its earnings guidance upwards
in anticipation of record
breaking third quarter results. The stock is up 14.9%
since March 19. The second stock, Escalon Medical,
has performed even better (+19.4%).
03/16/2004
--- Zimmer Sold For 697% Gain
in Seven and a Half Months.
Today we sold options in Zimmer Holdings for a gain
of 697% in seven and a half months. This is the equivalent
of a 2,619.8% return per year. Over the same time span, the
S&P 500 rose only 11.7%.
03/16/2004
--- Cimarex Sold
For 253% Gain in Seven and a Half Months.
Today we sold options in Cimarex Energy for a gain
of 253.2% in seven and a half months. This is the equivalent
of a 644.8% return per year. Over the same time span, the
S&P 500 rose only 11.7%.
03/13/2004
--- Are You Saving Enough?
Worksheets for Retirement Calculations
Continuing our series of best investing and personal finance
research sites on the Internet, today we've added links to
three great tools to assist in retirement planning.
Worksheet
1 (developed by T. Rowe Price) gives a quick estimate
of the total amount of money you're likely to need for retirement.
Worksheet
2 (developed by ING.com) also calculates retirement needs.
It's a good idea to try out both worksheet 1 and 2 as each
has their own methodology and may provide different answers
with seemingly equal inputs.
Worksheet
3 (also developed by T. Rowe Price) determines if your
retirement assets will last your lifetime.
Click here
to see the full list of Internet investment research sites
that we recommend.
03/08/2004
--- We've Found
the Needle In the Haystack
In today's Wall Street Journal, they listed the companies
whose stock prices have increased the most in the last three
years and the last twelve months. Of the thousands of U.S.
stocks available to invest in, we were able to have the foresight
to recommend what would become the 7th best stock
in the three year category: CarMax Group.
In the twelve-month category, the 24th
best stock was Gen-Probe, a stock that we recommended
14 months ago. The stock has returned 209% for subscribers
who invested in the company when we emailed our buy signal.
02/28/2004
--- Marine Products
Update: Stock Now Up 413% Since Our Buy Signal.
Marine Products stock rose another 12% this week, increasing
the total gain to 413% since our buy signal. On February 17,
Marine Products Corp. released
their 2003 fourth quarter and full year results. Earnings
per share for the quarter increased 51.1 percent over the
prior year's fourth quarter.
More Archived
Articles
Above are updates on some of our recommended
stocks and mutual funds. If you want to see exactly what stocks
and funds we recommend and when to buy and sell them, subscribe
today. You'll receive a complete listing of all of our recommended
stocks, mutual funds, and brokerage firms.
-Rex M. Jacobsen
Sr. Editor
|
